Jing Huang, Xinyue Ma, Jiao Yang, Jin Yang, Danfeng Dong. "Early toxicity–driven dose modification and efficacy of adjuvant abemaciclib in high-risk HR+/HER2− early breast cancer: A real-world study in Chinese patients.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.19_suppl.38